Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIVOSIRAN vs GLIPIZIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GIVOSIRAN vs GLIPIZIDE: Safety Overview

Metric GIVOSIRAN GLIPIZIDE
Total FAERS Reports 1,224 4,099
Deaths Reported 32 552
Death Rate 2.6% 13.5%
Hospitalizations 595 1,030
Average Patient Age 45.1 yrs 63.4 yrs
% Female Patients 89.5% 51.3%
FDA Approval Date Nov 20, 2019 Apr 26, 1994
Manufacturer Alnylam Pharmaceuticals, Inc. Bryant Ranch Prepack
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Discontinued